Table: Fuso Pharmaceutical -2019/20 parent results

Fuso Pharmaceutical Industries

12/05/2020 05:40

May 12 (Reuters)- 
          Fuso Pharmaceutical Industries Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           46.90           46.07          48.80        24.50    
               (+1.8 pct)      (+0.4 pct)     (+4.0 pct)    (+3.5 pct) 
  Operating        1.01            1.26           1.60       800 mln   
               (-19.9 pct)     (+58.0 pct)    (+58.3 pct)  (+37.8 pct) 
  Recurring        1.07            1.28           1.50       750 mln   
               (-16.6 pct)     (+53.7 pct)    (+40.6 pct)  (+19.4 pct) 
  Net            707 mln         894 mln          1.10       600 mln   
               (-21.0 pct)     (-7.7 pct)     (+55.5 pct)  (+38.4 pct) 
  EPS           80.59 yen      101.96 yen     125.36 yen    68.38 yen  
  Ann Div       60.00 yen       80.00 yen      60.00 yen               
  -Q2 Div       30.00 yen       40.00 yen      30.00 yen               
  -Q4 Div       30.00 yen       40.00 yen      30.00 yen               
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T